Discover 2,411 paid clinical trials in Rockville, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,411
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
for
Hepatitis
Location: Baltimore MD, Hershey PA, Charlottesville VA,
Sponsor: Bausch Health Americas, Inc.
Sex: All
Age: 18+
Code: NCT07428538
Phase3, Recruiting
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
for
Multiple Myeloma, Secondary Immunodeficiency
Location: Baltimore MD, Albany NY, Detroit MI, Montreal,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06980480
Phase3, Recruiting
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Baltimore MD, New Haven CT, Boston MA, Milwaukee WI,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07226349
Phase1, Recruiting
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
for
Schizophrenia, Schizoaffective Disorder
Location: Baltimore MD, New York NY, Chapel Hill NC, Augusta GA,
Sponsor: New York State Psychiatric Institute
Sex: All
Age: 18 - 65
Code: NCT05208190
Recruiting
New
Feasibility, Usability and Preliminary Efficacy of Home-based FES Fro Adhesive Capsulitis
for
Shoulder Adhesive Capsulitis
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT07227662
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Genomic Predictors of Recurrent Pregnancy Loss
for
Recurrent Pregnancy Loss
Location: Baltimore MD, Hershey PA, New York NY, New Haven CT,
Sponsor: Yale University
Sex: All
Age: 18 - 50
Code: NCT05444283
Recruiting
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
for
Sickle Cell Disease Vaso-occlusive Crisis
Location: Baltimore MD, Richmond VA, Pittsburgh PA, New York NY,
Sponsor: CSL Behring
Sex: All
Age: 12+
Code: NCT06699849
Phase2, Recruiting
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
for
Advanced Malignant Solid Neoplasm,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05691517
Phase1, Recruiting
CBT-CP for Veterans With SMI
for
Chronic Pain, Schizophrenia, Psychotic Disorders,
Location: Baltimore MD
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT06758414
Recruiting
Assessment of Fall Risks and Subject-specific Training for Fall Reduction
for
Fall Risk
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 60 - 70+
Code: NCT06396650
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
for
Renal Cell Carcinoma (RCC),
Location: Baltimore MD, Hershey PA, Charlottesville VA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05176483
Phase1, Recruiting
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
for
Aortic Aneurysm, Aortic Aneurysm and Dissection,
Location: Baltimore MD, Philadelphia PA, Milwaukee WI,
Sponsor: Vascutek Ltd.
Sex: All
Age: 18+
Code: NCT07078383
Recruiting
A Retrospective Study to Characterize Participants With Propionic Acidemia
for
Propionic Acidemia
Location: Baltimore MD, Philadelphia PA, Seattle WA
Sponsor: ModernaTX, Inc.
Sex: All
Age: 2+
Code: NCT05769621
Recruiting
Multi-Center Clean Air Randomized Controlled Trial in COPD
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Baltimore MD, Salisbury MD, West Reading PA,
Sponsor: JHSPH Center for Clinical Trials
Sex: All
Age: 40+
Code: NCT06376994
Phase3, Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease